Candriam Equities L Oncology Impact I/ LU1864482515 /
| NAV5/30/2023 | Chg.-29.4800 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,087.3201GBP | -1.39% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | - | 10.22 | 10.74 | 1.48 | -1.69 | 0.14 | 7.21 | -2.22 | 2.49 | 1.44 | - |
| 2021 | 0.09 | -5.90 | 1.24 | 1.97 | -2.18 | 6.26 | -1.59 | 6.66 | -1.78 | 1.68 | -2.99 | 1.57 | +4.39% |
| 2022 | -9.64 | -1.76 | 6.66 | -1.27 | -1.71 | 3.82 | 4.16 | 1.30 | -0.67 | 3.78 | 2.55 | -4.40 | +1.72% |
| 2023 | -0.19 | -2.26 | -0.73 | 1.15 | -1.29 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 13.56% | 14.13% | 16.78% | 16.56% | -% |
| Sharpe ratio | -0.85 | -1.28 | 0.21 | 0.05 | - |
| Best month | +1.15% | +2.55% | +4.16% | +10.74% | - |
| Worst month | -4.40% | -4.40% | -4.40% | -9.64% | - |
| Maximum loss | -7.49% | -9.40% | -10.11% | -18.83% | - |
| Outperformance | - | - | - | - | - |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,172.7000 | +5.74% | +12.94% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,318.7800 | +5.87% | +13.37% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.4300 | +0.89% | +2.28% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,087.3201 | +7.05% | +13.21% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,470.4301 | +5.40% | +11.86% | |
| Candriam Equities L Oncology Imp... | reinvestment | 227.8300 | +4.27% | +13.47% | |
| Candriam Equities L Oncology Imp... | paying dividend | 220.8000 | +4.42% | +8.87% | |
| Candriam Equities L Oncology Imp... | paying dividend | 177.2900 | +5.30% | +11.52% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,103.0000 | +2.68% | +11.09% | |
| Candriam Equities L Oncology Imp... | reinvestment | 147.8400 | +6.95% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,958.7700 | +1.84% | +5.11% | |
| Candriam Equities L Oncology Imp... | reinvestment | 239.4300 | +5.16% | +16.26% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.7000 | +0.50% | +0.98% | |
| Candriam Equities L Oncology Imp... | reinvestment | 260.6800 | +5.30% | +11.53% | |
| Candriam Equities L Oncology Imp... | reinvestment | 180.1000 | +1.77% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,638.4600 | +4.69% | +14.51% | |
| Candriam Equities L Oncology Imp... | reinvestment | 253.4600 | +3.71% | +11.42% |
Performance
| YTD | -3.30% | ||
|---|---|---|---|
| 6 Months | -7.56% | ||
| 1 Year | +7.05% | ||
| 3 Years | +13.21% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +39.15% | ||
| Year | |||
| 2022 | +1.72% | ||
| 2021 | +4.39% | ||